Sonnet BioTherapeutics Holdings, Inc.
SONN
$1.36
-$0.01-0.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.86M | 149.50K | 3.55M | 3.79M | 3.02M |
| Total Receivables | 666.80K | 762.10K | 519.60K | 378.00K | 194.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.20M | 1.21M | 1.05M | 1.06M | 1.41M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.73M | 2.12M | 5.13M | 5.22M | 4.62M |
|
|
|||||
| Total Current Assets | 6.73M | 2.12M | 5.13M | 5.22M | 4.62M |
| Net Property, Plant & Equipment | 121.70K | 143.90K | 165.50K | 186.60K | 207.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 335.10K | 509.10K | 503.50K | 499.80K | 506.90K |
| Total Assets | 7.18M | 2.77M | 5.80M | 5.91M | 5.34M |
|
|
|||||
| Total Accounts Payable | 1.64M | 2.18M | 1.88M | 1.75M | 1.66M |
| Total Accrued Expenses | 1.39M | 940.70K | 1.15M | 930.50K | 920.20K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 87.30K | 84.30K | 81.30K | 78.50K | 75.70K |
| Total Finance Division Other Current Liabilities | 1.70K | 1.80K | 2.60K | 3.30K | 3.00K |
| Total Other Current Liabilities | 1.70K | 1.80K | 2.60K | 3.30K | 3.00K |
| Total Current Liabilities | 3.12M | 3.21M | 3.11M | 2.76M | 2.65M |
|
|
|||||
| Total Current Liabilities | 3.12M | 3.21M | 3.11M | 2.76M | 2.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 23.60K | 46.60K | 68.80K | 90.40K | 111.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.15M | 3.26M | 3.18M | 2.86M | 2.77M |
|
|
|||||
| Common Stock & APIC | 124.88M | 117.20M | 117.17M | 114.10M | 113.98M |
| Retained Earnings | -120.84M | -117.68M | -114.55M | -111.05M | -111.41M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.04M | -485.70K | 2.62M | 3.05M | 2.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.04M | -485.70K | 2.62M | 3.05M | 2.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.04M | -485.70K | 2.62M | 3.05M | 2.57M |
|
|
|||||